CTOs on the Move

Poretta and Orr

www.porettaorr.com

 
Poretta and Orr, Inc. is a Doylestown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

VNA Healthcare Partners of Ohio

VNA Healthcare Partners of Ohio is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Openfit

Openfit is the place to go to get results and have fun doing it – an all-new digital streaming platform that integrates fitness, nutrition, and wellness together in one place. We offer world-class fitness programs with workouts designed to reach any goal, perfectly paired nutrition plans, safe and effective supplements, and customized wellness advice. In the process, we`ve searched far and wide to bring together the world`s foremost fitness and nutrition experts to make sure you succeed in reaching your goals. Whether you`re training for an extreme event, looking to lose weight, or just wanting to live each day a little healthier than the last – you`ll not only find solutions at Openfit, you`ll find inspiration. The kind that powers you through your workout and leaves you feeling pumped to do it again tomorrow. So you can reach your goals…and want to come back for more. That`s the simplicity of living a healthy, vibrant life – in your own way – every day. We hope you`ll come live yours at Openfit.

AVEO Pharmaceuticals

AVEO Pharmaceuticals, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. AVEO Pharmaceuticals, Inc. is based in Cambridge, MA. You can find more information on AVEO Pharmaceuticals, Inc. at www.aveopharma.com

Action Revenue Recovery

Action Revenue Recovery is a Monroe, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).